Financhill
Buy
64

FSLR Quote, Financials, Valuation and Earnings

Last price:
$274.85
Seasonality move :
5.03%
Day range:
$260.50 - $266.30
52-week range:
$116.56 - $285.99
Dividend yield:
0%
P/E ratio:
20.06x
P/S ratio:
5.56x
P/B ratio:
3.11x
Volume:
1.1M
Avg. volume:
1.8M
1-year change:
48.22%
Market cap:
$28B
Revenue:
$4.2B
EPS (TTM):
$13.02

Earnings Data

Next earnings date for FSLR
Feb 24
2026
Most recent earnings per share
$4.24
Beat by $0.02
(Oct 30/2025)
Consensus Estimate
$4.22
(Oct 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

FSLR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $1.3B -- -- $4.63 --
02/24/2026 Q4 $1.6B -- -- $5.22 --
10/30/2025 Q3 $1.6B $1.6B $4.24 $4.22 $0.02
07/31/2025 Q2 $1B $1.1B $3.18 $2.68 $0.50
04/29/2025 Q1 $843.7M $844.6M $1.95 $2.55 -$0.60
02/25/2025 Q4 $1.5B $1.5B $3.65 $4.73 -$1.07
10/29/2024 Q3 $1.1B $887.7M $2.91 $3.15 -$0.24
07/30/2024 Q2 $933.9M $1B $3.25 $2.66 $0.59
05/01/2024 Q1 $725.3M $794.1M $2.20 $2.02 $0.18
02/27/2024 Q4 $1.3B $1.2B $3.25 $3.13 $0.11
10/31/2023 Q3 -- $801.1M $2.50 -- --
07/27/2023 Q2 -- $810.7M $1.59 -- --
04/27/2023 Q1 -- $548.3M $0.40 -- --
02/28/2023 Q4 -- $1B -$0.07 -- --
10/27/2022 Q3 -- $628.9M -$0.46 -- --
07/28/2022 Q2 -- $621M $0.52 -- --
04/28/2022 Q1 -- $367M -$0.41 -- --
03/01/2022 Q4 -- $907.3M $1.23 -- --
11/04/2021 Q3 -- $583.5M $0.42 -- --
07/29/2021 Q2 -- $629.2M $0.77 -- --
04/29/2021 Q1 -- $803.4M $1.96 -- --
02/25/2021 Q4 -- $609.2M $1.08 -- --
10/27/2020 Q3 -- $927.6M $1.45 -- --
08/06/2020 Q2 -- $642.4M $0.35 -- --
05/07/2020 Q1 -- $531.9M $0.85 -- --
02/20/2020 Q4 -- $1.4B -$0.56 -- --
10/24/2019 Q3 -- $546.8M $0.29 -- --
08/01/2019 Q2 -- $584.8M -$0.18 -- --
05/02/2019 Q1 -- $532M -$0.64 -- --
02/21/2019 Q4 -- $691.2M $0.49 -- --
10/25/2018 Q3 -- $676.2M $0.54 -- --
07/26/2018 Q2 -- $309.3M -$0.46 -- --
04/26/2018 Q1 -- $567.3M $0.78 -- --
02/22/2018 Q4 -- $339.2M -$4.14 -- --
10/26/2017 Q3 -- $1.1B $1.95 -- --
07/27/2017 Q2 -- $623.3M $0.50 -- --
05/02/2017 Q1 -- $891.8M $0.09 -- --
02/21/2017 Q4 -- $330.8M -$7.30 -- --
11/02/2016 Q3 -- $681.3M $1.45 -- --
08/03/2016 Q2 -- $1B -$0.11 -- --
04/27/2016 Q1 -- $876.1M $1.90 -- --

First Solar, Inc. Earnings Questions

  • How Much did First Solar, Inc. Generate in Revenue Last Quarter?

    First Solar, Inc. reported $1.6B worth of top line sales in its most recent quarter.

  • Did First Solar, Inc. Beat Earnings Last Quarter?

    First Solar, Inc. announced earnings per share of $4.24 which represents a beat of analyst forecast a $4.22 per share.

  • Is First Solar, Inc. Profitable?

    First Solar, Inc. reported $610.7M that represents $5.68 per share over the last quarter.

  • What is the Analyst Consensus for First Solar, Inc. EPS Next Year?

    First Solar, Inc.'s earnings are forecast to grow from $12.02 per share to $14.62 per share next year representing an increase of 21.66%.

  • When is First Solar, Inc.'s Earnings Date?

    First Solar, Inc.'s next earnings date is February 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.92% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 2.76% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 8.14% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock